NeostenineCAS# 477953-07-4 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 477953-07-4 | SDF | Download SDF |
PubChem ID | 11536426 | Appearance | Powder |
Formula | C17H27NO2 | M.Wt | 277.4 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (1S,9R,10R,11R,14S,15R,16R)-10-ethyl-14-methyl-12-oxa-4-azatetracyclo[7.6.1.04,16.011,15]hexadecan-13-one | ||
SMILES | CCC1C2CCCCN3C2C(CC3)C4C1OC(=O)C4C | ||
Standard InChIKey | ROIHYOJMCBKEER-FGBMJVKNSA-N | ||
Standard InChI | InChI=1S/C17H27NO2/c1-3-11-12-6-4-5-8-18-9-7-13(15(12)18)14-10(2)17(19)20-16(11)14/h10-16H,3-9H2,1-2H3/t10-,11+,12+,13-,14-,15+,16+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Neostenine shows significant antitussive activities. |
Neostenine Dilution Calculator
Neostenine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.6049 mL | 18.0245 mL | 36.049 mL | 72.0981 mL | 90.1226 mL |
5 mM | 0.721 mL | 3.6049 mL | 7.2098 mL | 14.4196 mL | 18.0245 mL |
10 mM | 0.3605 mL | 1.8025 mL | 3.6049 mL | 7.2098 mL | 9.0123 mL |
50 mM | 0.0721 mL | 0.3605 mL | 0.721 mL | 1.442 mL | 1.8025 mL |
100 mM | 0.036 mL | 0.1802 mL | 0.3605 mL | 0.721 mL | 0.9012 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 3-(2-Glucosyloxy-4-methoxyphenyl)propanoic acid
Catalog No.:BCN7068
CAS No.:477873-63-5
- PIM-1 Inhibitor 2
Catalog No.:BCC2446
CAS No.:477845-12-8
- Tofacitinib (CP-690550,Tasocitinib)
Catalog No.:BCC2192
CAS No.:477600-75-2
- PHA-665752
Catalog No.:BCC1181
CAS No.:477575-56-7
- Musellarin A
Catalog No.:BCN7186
CAS No.:477565-36-9
- Sculponeatin K
Catalog No.:BCN5537
CAS No.:477529-70-7
- Ophiopogonanone C
Catalog No.:BCN6620
CAS No.:477336-75-7
- cis-ACPD
Catalog No.:BCC6566
CAS No.:477331-06-9
- (±)-AC 7954 hydrochloride
Catalog No.:BCC7381
CAS No.:477313-09-0
- Mangiferin
Catalog No.:BCN5535
CAS No.:4773-96-0
- Bergenin
Catalog No.:BCN5540
CAS No.:477-90-7
- Digitolutein
Catalog No.:BCN3089
CAS No.:477-86-1
- Nobiletin
Catalog No.:BCN5542
CAS No.:478-01-3
- Lucidin
Catalog No.:BCC1709
CAS No.:478-08-0
- Pseudoaspidin
Catalog No.:BCN6386
CAS No.:478-28-4
- Eleutherin
Catalog No.:BCN8475
CAS No.:478-36-4
- Droserone
Catalog No.:BCN7985
CAS No.:478-40-0
- Rhein
Catalog No.:BCN5947
CAS No.:478-43-3
- Berbamine
Catalog No.:BCN5543
CAS No.:478-61-5
- Pseudococaine
Catalog No.:BCN1902
CAS No.:478-73-9
- PHA 543613 hydrochloride
Catalog No.:BCC5972
CAS No.:478149-53-0
- Isoerysenegalensein E
Catalog No.:BCN3978
CAS No.:478158-77-9
- R-1479
Catalog No.:BCC1878
CAS No.:478182-28-4
- Gabapentin enacarbil
Catalog No.:BCC4239
CAS No.:478296-72-9
Isolation, characterization and acetylcholinesterase inhibitory activity of alkaloids from roots of Stemona sessilifolia.[Pubmed:23831460]
Fitoterapia. 2013 Sep;89:257-64.
Two new alkaloids, named stenine A (1) and stenine B (2), along with the known compounds Neostenine (3), stenine (4) and neotuberostemonine (5), were isolated from the roots of Stemona sessilifolia. Their structures were elucidated by 1D- and 2D-NMR spectra and X-ray single-crystal diffraction experiment. Anti-acetylcholinesterase (AChE) activity of compounds 1-5 were also tested. Compounds 2 and 4 showed significant anti-acetylcholinesterase activities, with IC50 values of 2.1+/-0.2 muM and 19.8+/-2.5 muM, resp. The mode of AChE inhibition by Compound 2 (the most potential AChE inhibitor) was reversible and competitive. In addition, molecular modeling was performed to explore the binding mode of compound 2 with AChE.